A comparison of three stool tests for colorectal cancer screening.
The annual guaiac or immunochemical fecal occult blood test (FOBT) is one of the five colorectal cancer (CRC) screening regimens recommended by the American Cancer Society (Smith, Cokkinides, & Eyre, 2005). Stool-based deoxyribonucleic acid (DNA) testing for CRC is considered a promising technology (Smith, Cokkinides, & Eyre, 2003). Numerous features of three noninvasive stool tests for CRC are compared.
Greenwald
Beverly
B
Department of Nursing, North Dakota State University, Fargo, ND, USA.
D000359:Aftercare; D015982:Bias; D003113:Colonoscopy; D015179:Colorectal Neoplasms / Q000175:diagnosis* / Q000453:epidemiology; D003362:Cost-Benefit Analysis; D004273:DNA, Neoplasm / Q000032:analysis*; D005188:False Negative Reactions; D005189:False Positive Reactions; D006138:Guaiac / Q000191:economics / Q000592:standards*; D006801:Humans; D007120:Immunochemistry / Q000191:economics / Q000592:standards*; D007202:Indicators and Reagents / Q000191:economics / Q000592:standards*; D008403:Mass Screening / Q000191:economics / Q000379:methods* / Q000592:standards; D009017:Morbidity; D009780:Occult Blood; D010349:Patient Compliance; D010808:Physical Examination; D017410:Practice Guidelines as Topic; D015203:Reproducibility of Results; D012680:Sensitivity and Specificity; D013048:Specimen Handling / Q000191:economics / Q000379:methods / Q000592:standards; D015996:Survival Rate
D004273:DNA, Neoplasm; D007202:Indicators and Reagents; D006138:Guaiac